NCT01833039

Brief Summary

The purpose of this study is to provide patients who have relapsed or refractory Mantle Cell Lymphoma (MCL) with early access to an investigational medication called ibrutinib (PCI-32765) and to collect safety information about the drug.

Trial Health

60
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
3 countries

51 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 6, 2013

Completed
10 days until next milestone

First Posted

Study publicly available on registry

April 16, 2013

Completed
Last Updated

February 3, 2025

Status Verified

January 1, 2025

First QC Date

April 6, 2013

Last Update Submit

January 31, 2025

Conditions

Keywords

Mantle Cell LymphomaIbrutinib

Interventions

Ibrutinib

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients, 18 years of age and older, with Mantle Cell Lymphoma who have relapsed or refractory disease after prior therapy are eligible.

You may not qualify if:

  • Patients eligible for enrollment in any other ongoing clinical study of ibrutinib are not eligible.
  • Patients previously treated with ibrutinib are not eligible.
  • Patients enrolled in another interventional clinical study with therapeutic intent are not eligible.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (51)

Unknown Facility

Phoenix, Arizona, United States

Location

Unknown Facility

Duarte, California, United States

Location

Unknown Facility

Los Angeles, California, United States

Location

Unknown Facility

Stanford, California, United States

Location

Unknown Facility

Denver, Colorado, United States

Location

Unknown Facility

Norwalk, Connecticut, United States

Location

Unknown Facility

Stamford, Connecticut, United States

Location

Unknown Facility

Washington D.C., District of Columbia, United States

Location

Unknown Facility

Miami Beach, Florida, United States

Location

Unknown Facility

Ocala, Florida, United States

Location

Unknown Facility

Orlando, Florida, United States

Location

Unknown Facility

Atlanta, Georgia, United States

Location

Unknown Facility

Chicago, Illinois, United States

Location

Unknown Facility

Springfield, Illinois, United States

Location

Unknown Facility

Goshen, Indiana, United States

Location

Unknown Facility

Sioux City, Iowa, United States

Location

Unknown Facility

Lexington, Kentucky, United States

Location

Unknown Facility

Louisville, Kentucky, United States

Location

Unknown Facility

Metairie, Louisiana, United States

Location

Unknown Facility

Baltimore, Maryland, United States

Location

Unknown Facility

Boston, Massachusetts, United States

Location

Unknown Facility

Worcester, Massachusetts, United States

Location

Unknown Facility

Detroit, Michigan, United States

Location

Unknown Facility

Rochester, Minnesota, United States

Location

Unknown Facility

Jefferson City, Missouri, United States

Location

Unknown Facility

St Louis, Missouri, United States

Location

Unknown Facility

Lincoln, Nebraska, United States

Location

Unknown Facility

Omaha, Nebraska, United States

Location

Unknown Facility

Reno, Nevada, United States

Location

Unknown Facility

Hackensack, New Jersey, United States

Location

Unknown Facility

New Hyde Park, New York, United States

Location

Unknown Facility

New York, New York, United States

Location

Unknown Facility

Syracuse, New York, United States

Location

Unknown Facility

Cleveland, Ohio, United States

Location

Unknown Facility

Columbus, Ohio, United States

Location

Unknown Facility

Hershey, Pennsylvania, United States

Location

Unknown Facility

Philadelphia, Pennsylvania, United States

Location

Unknown Facility

Watertown, South Dakota, United States

Location

Unknown Facility

Knoxville, Tennessee, United States

Location

Unknown Facility

Austin, Texas, United States

Location

Unknown Facility

Dallas, Texas, United States

Location

Unknown Facility

Houston, Texas, United States

Location

Unknown Facility

Burlington, Vermont, United States

Location

Unknown Facility

Morgantown, West Virginia, United States

Location

Unknown Facility

Barretos, Brazil

Location

Unknown Facility

Florianópolis, Brazil

Location

Unknown Facility

Porto Alegre, Brazil

Location

Unknown Facility

Rio de Janeiro, Brazil

Location

Unknown Facility

Salvador, Brazil

Location

Unknown Facility

São Paulo, Brazil

Location

Unknown Facility

San Juan, Puerto Rico

Location

Related Links

MeSH Terms

Conditions

RecurrenceLymphoma, Mantle-Cell

Interventions

ibrutinib

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsLymphoma, Non-HodgkinLymphomaNeoplasms by Histologic TypeNeoplasmsLymphoproliferative DisordersLymphatic DiseasesHemic and Lymphatic DiseasesImmunoproliferative DisordersImmune System Diseases

Study Design

Study Type
expanded access
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 6, 2013

First Posted

April 16, 2013

Last Updated

February 3, 2025

Record last verified: 2025-01

Locations